The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles
Open accessAbstract
Alzheimer's disease is the commonest cause of dementia in the elderly, but its pathological determinants are still debated. Amyloid-β plaques and neurofibrillary tangles have been implicated either directly as disruptors of neural function, or indirectly by precipitating neuronal death and thus causing a reduction in neuronal number. Alternatively, the initial cognitive decline has been attributed to subtle intracellular events caused by amyloid-β oligomers, resulting in dementia after massive synaptic dysfunction followed by neuronal degeneration and death. To investigate whether Alzheimer's disease is associated with changes in the absolute cell numbers of ageing brains, we used the isotropic fractionator, a novel technique designed to determine the absolute cellular composition of brain regions. We investigated whether plaques and tangles are associated with neuronal loss, or whether it is dementia that relates to changes of absolute cell composition, by comparing cell numbers in brains of patients severely demented with those of asymptomatic individuals-both groups histopathologically diagnosed as Alzheimer's-and normal subjects with no pathological signs of the disease. We found a great reduction of neuronal numbers in the hippocampus and cerebral cortex of demented patients with Alzheimer's disease, but not in asymptomatic subjects with Alzheimer's disease. We concluded that neuronal loss is associated with dementia and not the presence of plaques and tangles, which may explain why subjects with histopathological features of Alzheimer's disease can be asymptomatic; and exclude amyloid-β deposits as causes for the reduction of neuronal numbers in the brain. We found an increase of non-neuronal cell numbers in the cerebral cortex and subcortical white matter of demented patients with Alzheimer's disease when compared with asymptomatic subjects with Alzheimer's disease and control subjects, suggesting a reactive glial cell response in the former that may be related to the symptoms they present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · cited 1×
“…has been related to anomalous cell cycle re-entrance before neuronal death (Herrup, 2010, 2012), presumably causing a relevant reduction in the number of neurons, and the subsequent progressive cognitive impairment that ends in dementia (Whitehouse et al ., 1982; Neniskyte et al ., 2011).”
Marr, D. (1969) · The Journal of Physiology · doi:10.1113/jphysiol.1969.sp008820 · Cited by 3,253
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
NeuN, a neuronal specific nuclear protein in vertebratesxs
Mullen, R. J., Buck, C. R., & Smith, A. M. (1992) · Development · doi:10.1242/dev.116.1.201 · Cited by 2,351
Azevedo, F. A. C., Carvalho, L. R. B., Grinberg, L. T., Farfel, J. M., Ferretti, R. E. L., Leite, R. E. P., Filho, W. J., Lent, R., & Herculano‐Houzel, S. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21974 · Cited by 2,337 · cited 4×
“…some pathology studies have suggested that Alzheimer’s syndrome actually begins in the brainstem and dis-seminates throughout the brain (Yamamoto and Hirano, 1985; Hardy et al ., 1986; German et al ., 1987; Grinberg et al ., 2009; Simic et al ., 2009; Braak et al ., 2011; Grinberg et al ., 2011).”
InfluentialSelf-citationAlzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · cited 1×
“…and neurofibril-lary tangles have often been considered as the main pathological hallmarks of Alzheimer’s disease (Mattson, 2004; Nestor et al ., 2004; Palop and Mucke, 2010), despite growing post-mortem evidence for amyloid-b deposition in the cognitively normal elderly (Price and Morris, 1999;…”
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Life and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · cited 1×
“…considered as the main pathological hallmarks of Alzheimer’s disease (Mattson, 2004; Nestor et al ., 2004; Palop and Mucke, 2010), despite growing post-mortem evidence for amyloid-b deposition in the cognitively normal elderly (Price and Morris, 1999; Bennett et al ., 2006; Negash et al ., 2011).”
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · cited 1×
“Alternative explanations have been proposed, such as a synaptic attack by amyloid-b oligomers (Gong et al., 2003; Lacor et al., 2004; Vieira et al., 2007; Ferreira and Klein, 2011; Sebollela et al., 2012), and tau hyperphosphorylation (De Felice et al.”
BackgroundSynaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876
Perforant pathway changes and the memory impairment of Alzheimer's disease
Hyman, B. T., Van Hoesen, G. W., Kromer, L. J., & Damasio, A. R. (1986) · Annals of Neurology · doi:10.1002/ana.410200406 · Cited by 672
Ball, M. J. (1977) · Acta Neuropathologica · doi:10.1007/bf00692056 · Cited by 639 · cited 1×
“Classical studies have proposed that neuronal loss therein is a morphological correlate of memory impairment in Alzheimer’s disease (Ball, 1977; Hyman et al ., 1984; Mani et al ., 1986).”
Neocortical glial cell numbers in human brains
Pelvig, D. P., Pakkenberg, H., Stark, A. K., & Pakkenberg, B. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.013 · Cited by 601 · cited 1×
“As these represent the majority of glial cell types in the brain (Pelvig et al., 2008), functional, morphological (Rodrı́guez et al.”
Schmahmann, J. D. (2010) · Neuropsychology Review · doi:10.1007/s11065-010-9142-x · Cited by 583 · cited 1×
“…and learning (Marr, 1969; Thach, 1998; Wegiel et al ., 1999; Boyden et al ., 2004; Morton and 2004), recent studies implicate it in non-motor functions, such as cognitive, behavioural and affective processing (Ito, 1989; Leiner et al ., 1991; Bower, 1997; Timmann and Daum, 2007; Schmahmann, 2010).”
: Cellular scaling rules for rodent brains.
Herculano-Houzel, S., Mota, B., & Lent, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604911103 · Cited by 579 · cited 1×
“The quantitative contribution of these cells as compared with the total brain numbers, however, is negligible (Herculano-Houzel and Lent, 2005; Herculano-Houzel et al ., 2006).”
Self-citationStrongly reduced volumes of putamen and thalamus in Alzheimer’s disease: an MRI study
de Jong, L. W., van der Hiele, K., Veer, I. M., Houwing, J. J., Westendorp, R. G. J., Bollen, E. L. E. M., de Bruin, P. W., Middelkoop, H. A. M., van Buchem, M. A., & van der Grond, J. (2008) · Brain · doi:10.1093/brain/awn278 · Cited by 557
Herculano-Houzel, S., & Lent, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4526-04.2005 · Cited by 551 · cited 4×
“To clarify these inconsistencies, we sought to use the isotropic fractionator (Herculano-Houzel and Lent, 2005) to investigate whether dementia is associated with changes in the quantitative cellular composition of ageing brains.”
InfluentialSelf-citationNeocortical neurogenesis in humans is restricted to development
Bhardwaj, R. D., Curtis, M. A., Spalding, K. L., Buchholz, B. A., Fink, D., Björk-Eriksson, T., Nordborg, C., Gage, F. H., Druid, H., Eriksson, P. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605177103 · Cited by 448 · cited 1×
“Because neurons in the human cortex seem not to be significantly replaced after birth (Rakic, 1985; Bhardwaj et al., 2006), it is conceivable that neuronal loss can lead to irreversible cognitive changes.”
BackgroundThe Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442 · cited 2×
“…explanations have been proposed, such as a synaptic attack by amyloid-b oligomers (Gong et al ., 2003; Lacor et al ., 2004; Vieira et al ., 2007; Ferreira and Klein, 2011; Sebollela et al ., 2012), and tau hyperphosphorylation (De Felice et al ., 2008; Jin et al ., 2011; Flunkert et al .,…”
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
De Felice, F. G., Wu, D., Lambert, M. P., Fernandez, S. J., Velasco, P. T., Lacor, P. N., Bigio, E. H., Jerecic, J., Acton, P. J., Shughrue, P. J., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.029 · Cited by 432
Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease
Bruen, P. D., McGeown, W. J., Shanks, M. F., & Venneri, A. (2008) · Brain · doi:10.1093/brain/awn151 · Cited by 374
Villain, N., Desgranges, B., Viader, F., de la Sayette, V., Mezenge, F., Landeau, B., Baron, J.-C., Eustache, F., & Chetelat, G. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1392-08.2008 · Cited by 366
Hippocampal neurons in pre-clinical Alzheimer's disease.
West, M. J., Kawas, C. H., Stewart, W. F., Rudow, G. L., & Troncoso, J. C. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.005 · Cited by 317 · cited 1×
“Our results are in agreement with these histopathological findings, and support previous stereological (Kril et al., 2004; West et al., 2004) and neuroimaging studies (Apostolova et al.”
ResultImmune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease
Vehmas, A. K., Kawas, C. H., Stewart, W. F., & Troncoso, J. C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00090-8 · Cited by 230
Does Alzheimer's disease begin in the brainstem?
Simic, G., Stanic, G., Mladinov, M., Jovanov‐Milosevic, N., Kostovic, I., & Hof, P. R. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01038.x · Cited by 204
MICHELSEN, K., PRICKAERTS, J., & STEINBUSCH, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00912-6 · Cited by 196 · cited 2×
“These authors argue that the current clinical criteria for Alzheimer’s disease diagnosis are focused on cognitive deficits produced by dysfunction of hippocampal and high order neocortical areas, whereas other behavioural and psychological symptoms of dementia such as disturbances in mood, emotion, wake-sleep cycle, c…”
Brazilian Aging Brain Study Group, Grinberg, L. T., de Lucena Ferretti, R. E., Farfel, J. M., Leite, R., Pasqualucci, C. A., Rosemberg, S., Nitrini, R., Saldiva, P. H. N., & Jacob Filho, W. (2007) · Cell and Tissue Banking · doi:10.1007/s10561-006-9022-z · Cited by 169
Self-citationBurns, J. M., Church, J. A., Johnson, D. K., Xiong, C., Marcus, D., Fotenos, A. F., Snyder, A. Z., Morris, J. C., & Buckner, R. L. (2005) · Archives of Neurology · doi:10.1001/archneur.62.12.1870 · Cited by 155 · cited 1×
“…with dementia, not with plaques and tangles It has been proposed that reduction of white matter volume may be associated with weakening of cognitive functions because of a fall in propagation speed of electrical impulses (Marner et al ., 2003; Burns et al ., 2005; Jørgensen et al ., 2008).”
Oskar Fischer and the study of dementia
Goedert, M. (2008) · Brain · doi:10.1093/brain/awn256 · Cited by 144 · cited 1×
“Since its first description (Alzheimer, 1907; Fischer, 1907; Goedert, 2009), amyloid-b neuritic plaques and neurofibril-lary tangles have often been considered as the main pathological hallmarks of Alzheimer’s disease (Mattson, 2004; Nestor et al ., 2004; Palop and Mucke, 2010), despite growing…”
Pathological Substrates of Cognitive Decline in Alzheimer’s Disease
Giannakopoulos, P., Kövari, E., Gold, G., von Gunten, A., Hof, P. R., & Bouras, C. (2009) · Frontiers of Neurology and Neuroscience · doi:10.1159/000197881 · Cited by 101 · cited 1×
“Indeed, a significant neuronal loss was reported in the hippocampus of patients with Alzheimer’s disease (Simic et al ., 1997, Korbo et al ., 2004; Giannakopoulos et al ., 2009).”
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old
Polvikoski, T. M., van Straaten, E. C. W., Barkhof, F., Sulkava, R., Aronen, H. J., Niinistö, L., Oinas, M., Scheltens, P., Erkinjuntti, T., & Kalaria, R. N. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d6f9 · Cited by 88 · cited 1×
“Using post-mortem MRI and neuropathological approaches, Polvikoski et al .”
Neocortical Glial Cell Numbers in Alzheimer’s Disease
Pelvig, D. P., Pakkenberg, H., Regeur, L., Oster, S., & Pakkenberg, B. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000072805 · Cited by 81 · cited 1×
“…in demented patients with Alzheimer’s disease as compared with cognitively normal and asymptomatic subjects with Alzheimer’s disease in both white and grey matters of the cerebral cortex, more pronounced in the frontal lobe than elsewhere, in contrast to another report (Pelvig et al ., 2003).”
Cited by
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
“Patients with mild-to-moderate AD-type neurofibrillary degeneration in the medial temporal lobe, but lacking A β plaques, have been described in European, Japanese, North and South American cohorts [2, 3, 14, 51, 52, 58, 69, 72, 79, 81, 82, 126, 142, 147, 149, 151].”
BackgroundSelf-citationvon Bartheld, C. S., Bahney, J., & Herculano‐Houzel, S. (2016) · Journal of Comparative Neurology · doi:10.1002/cne.24040 · Cited by 1,063
“Automated versions of the IF have been reported, both for the homogenization procedure (Azevedo et al., 2013) and for the counting procedure, using flow cytometry (Collins et al., 2010; Young et al., 2012; Herculano-Houzel et al., 2015).”
BackgroundMethodResultInfluentialCerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Theofilas, P., Ehrenberg, A. J., Dunlop, S., Di Lorenzo Alho, A. T., Nguy, A., Leite, R. E. P., Rodriguez, R. D., Mejia, M. B., Suemoto, C. K., Ferretti-Rebustini, R. E. D. L., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.2362 · Cited by 416
Self-citationMonoaminergic neuropathology in Alzheimer’s disease
Šimić, G., Babić Leko, M., Wray, S., Harrington, C. R., Delalle, I., Jovanov-Milošević, N., Bažadona, D., Buée, L., de Silva, R., Di Giovanni, G., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.001 · Cited by 289
Metadata
- Authors
- Andrade-Moraes, C. H., Oliveira-Pinto, A. V., Castro-Fonseca, E., da Silva, C. G., Guimaraes, D. M., Szczupak, D., Parente-Bruno, D. R., Carvalho, L. R. B., Polichiso, L., Gomes, B. V., Oliveira, L. M., Rodriguez, R. D., Leite, R. E. P., Ferretti-Rebustini, R. E. L., Jacob-Filho, W., Pasqualucci, C. A., Grinberg, L. T., & Lent, R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-17
- Volume
- 136
- Issue
- 12
- Pages
- 3738-3752
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2151027049
- Cited by
- 216
- References
- 44
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.